The pharmaceutical industry continues to develop new medicines and dosage forms to meet different healthcare needs. Injectable medicines are widely used in hospitals, clinics, and other medical facilities. Their production requires specialised equipment, trained staff, and strict control over manufacturing conditions.
Setting up an injectable manufacturing facility requires significant investment in infrastructure, machinery, testing equipment, and skilled professionals. For businesses that want to offer injectable products without establishing their own production unit, working with an external manufacturer can be a practical option.
Through injection third-party manufacturing, pharmaceutical businesses can get injectable products manufactured by an experienced production partner while managing their own sales, distribution, and business development activities.
Understanding Injectable Medicines
Injectable medicines are pharmaceutical preparations administered into the body using a suitable injection method. They are used for different medical purposes, depending on the active ingredient, formulation, and intended treatment.
Unlike many oral medicines, injectables must meet specific requirements related to sterility, purity, and packaging. The manufacturing process is designed to protect the product from contamination and maintain its quality throughout its shelf life.
Some commonly manufactured injectable dosage forms include:
-
Liquid injections: These contain an active pharmaceutical ingredient dissolved or dispersed in a suitable liquid.
-
Dry powder injections: These are supplied as powders and may require mixing with a suitable liquid before administration.
-
Injectable suspensions: These contain finely distributed particles of an active ingredient in a liquid medium.
Each dosage form has different formulation, processing, and storage requirements. Therefore, product selection should be based on the intended use and applicable regulatory requirements.
How Does the Manufacturing Arrangement Work?
In a third-party arrangement, the pharmaceutical business selects the products it wants to market and discusses the manufacturing requirements with a suitable production company.
The manufacturer reviews the product specifications, production requirements, packaging details, and expected batch quantity. Once both parties agree on the terms, manufacturing can proceed according to the approved process and applicable requirements.
The general process includes:
-
Product selection: The business identifies the injectable medicines it wants to include in its portfolio.
-
Technical discussion: Both parties discuss formulation, strength, packaging, and batch requirements.
-
Manufacturing planning: Raw materials, production schedules, and quality requirements are reviewed.
-
Production and testing: The manufacturer produces the batch and carries out the required quality checks.
-
Packaging and dispatch: Approved products are packed, documented, and supplied according to the agreement.
The responsibilities of each party should be clearly defined before the manufacturing process begins.
Importance of Formulation and Raw Materials
Formulation development is an important part of injectable medicine production. The ingredients used in a formulation must be suitable for the intended product and compatible with one another.
Apart from the active pharmaceutical ingredient, a formulation may contain suitable solvents, stabilisers, or other excipients, depending on its requirements.
Raw materials should be sourced from appropriate suppliers and checked against established specifications. Their identity, purity, and quality can affect the safety, stability, and consistency of the finished medicine.
Manufacturers must also consider the compatibility of the formulation with its container. This helps ensure that the packaging does not adversely affect product quality during storage.
Sterile Production and Manufacturing Controls
Sterility is one of the most important requirements for injectable medicines. The manufacturing facility must have suitable infrastructure and procedures to control contamination during production.
Cleanrooms, controlled air systems, sanitisation procedures, and environmental monitoring help maintain appropriate manufacturing conditions. Equipment must be cleaned and maintained according to established procedures.
Depending on the formulation, manufacturers may use terminal sterilisation or aseptic processing. The method selected must be appropriate for the product and supported by suitable validation.
Personnel working in sterile manufacturing areas also require specialised training. Proper gowning, hygiene practices, and controlled movement within production areas help reduce contamination risks.
Quality Testing and Documentation
Quality control helps verify that an injectable product meets its approved specifications before release. The tests performed depend on the product type, formulation, and applicable standards.
Common quality checks may include:
-
Identification and strength of the active ingredient.
-
Sterility and bacterial endotoxin testing.
-
Particulate matter testing.
-
Visual inspection and container closure checks.
-
Stability studies and shelf-life assessment.
Manufacturing records and batch test reports are also important. They provide information about the production process, testing results, and product quality.
Pharmaceutical businesses should clarify which documents will be supplied with each batch and how quality complaints or product-related issues will be handled.
What Should Businesses Check Before Choosing a Manufacturer?
When evaluating injection third-party manufacturing, businesses should review the manufacturer's production capabilities, regulatory documentation, and quality management procedures rather than focusing only on the quoted price.
A few important considerations include:
-
Manufacturing licences and applicable approvals for the required products.
-
Experience with the specific injectable dosage forms.
-
Suitable sterile production facilities and testing arrangements.
-
Minimum order quantities and production timelines.
-
Packaging options, storage conditions, and transportation requirements.
The manufacturing agreement should clearly explain pricing, payment terms, product specifications, delivery schedules, and the responsibilities of both parties. Businesses should independently verify certification and regulatory claims before making a decision.
Managing Distribution and Product Supply
For businesses involved in injectable medicine distribution, supply planning is another important consideration. Hospitals and medical distributors may have specific requirements regarding product availability, packaging, and delivery schedules.
Companies should plan their inventory according to expected demand, product shelf life, and storage requirements. Injectable medicines that require temperature-controlled storage need suitable transportation and monitoring arrangements.
Clear communication between the manufacturing partner and the marketing business can help coordinate production schedules and avoid unnecessary supply delays.
Conclusion
For pharmaceutical companies, injection third-party manufacturing offers a way to develop an injectable product portfolio without building an independent production facility. However, the arrangement requires careful planning, appropriate manufacturer selection, and a clear understanding of quality and regulatory responsibilities.
By reviewing manufacturing capabilities, product requirements, documentation, and distribution needs, businesses can establish a more organised production arrangement and plan their pharmaceutical operations with greater clarity.
Comments (0)